Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,137.68 +58.82 (+0.73%) Bitcoin USD
63,815.88 +546.28 (+0.86%) CMC Crypto 200
1,330.34 -66.20 (-4.74%)
Editas Medicine, Inc. (EDIT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 11:07AM EDT. Market open.
| Previous close | 5.22 |
| Open | 5.25 |
| Bid | 5.27 x 1200 |
| Ask | 5.40 x 100 |
| Day's range | 5.13 - 5.39 |
| 52-week range | 5.11 - 11.91 |
| Volume | |
| Avg. volume | 1,924,445 |
| Market cap | 437.077M |
| Beta (5Y monthly) | 2.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Why Is Editas (EDIT) Down 26.2% Since Last Earnings Report?
Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GuruFocus.com
Insider Sells Shares of Editas Medicine Inc (EDIT)
Editas Medicine Inc (NASDAQ:EDIT), a leading genome editing company, focuses on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world.
- Simply Wall St.
Editas Medicine, Inc. (NASDAQ:EDIT) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Editas Medicine, Inc. ( NASDAQ:EDIT ) just released its latest full-year results and things are looking bullish...
© 2024 Yahoo. All rights reserved.